Table 7.
| A. Hib-N. mening CY-T | |||||||
|---|---|---|---|---|---|---|---|
| Reference | Authors | Year Published | Study | Population | Country | ||
| 214 | Marshall, Marchant, Blatter et al. | 2011 | Ph II | Infants | USA | ||
| 215 | Nolan, Richmond, Marshall et al. | 2011 | Ph II | Infants | USA | ||
| B. Spn-OMPC | |||||||
| Reference | Authors | Year Published | Study | Vaccine | Population | Country | |
| 169 | Kayhty, Ahman, Ronnberg et al. | 1995 | ND* | 4-Valent | Infants/Toddlers | Finland | |
| 114 | Dagan, Melamed, Mualiem et al. | 1996 | ND | 7-Valent | Toddlers | Israel | |
| 238 | Miernyk, Parkinson, Rudolph et al. | 2000 | ND | 7-Valent | Infants | USA | |
| 275 | Blum, Dagan, Mendelman et al. | 2000 | ND | 7-Valent | Toddlers | Israel | |
| 218 | Kilpi, Ahman, Jokinen | 2003 | ND | 7-Valent | Infants | Finland | |
| 276 | Zangwill, Greenberg, Chiu et al. | 2003 | ND | 7-Valent | Infants | USA | |
| C. Spn-HiD | |||||||
| Reference | Authors | Year Published | Study | Vaccine | Population | Country | |
| 219 | Prymula, Peeters, Chrobok et al. | 2006 | ND* | 11-Valent | Infants | Czech Republic, Slovak Republic | |
| 220 | Prymula, Chlibek, Splino et al. | 2008 | ND | 11-Valent | Infants | Czech Republic, Slovak Republic | |
| 221 | Knuf, Szenborn, Moro et al. | 2009 | ND | 10-Valent† | Infants | Finland, France, Poland, Germany Spain, Philippines | |
*ND, study phase not discerned; †8 of the 10 vaccine serotypes conjugated to HiD.